432 related articles for article (PubMed ID: 21672081)
1. Is there any rationale for treatment of Staphylococcus aureus infections with antimicrobials that are determined to be ineffective in vitro?
Uekötter A; Peters G; Becker K
Clin Microbiol Infect; 2011 Aug; 17(8):1142-7. PubMed ID: 21672081
[TBL] [Abstract][Full Text] [Related]
2. Antimicrobial susceptibility of Staphylococcus aureus and characterization of methicillin-resistant Staphylococcus aureus isolated from bovine mastitis in Korea.
Nam HM; Lee AL; Jung SC; Kim MN; Jang GC; Wee SH; Lim SK
Foodborne Pathog Dis; 2011 Feb; 8(2):231-8. PubMed ID: 21034263
[TBL] [Abstract][Full Text] [Related]
3. Antimicrobial resistance: Not community-associated methicillin-resistant Staphylococcus aureus (CA-MRSA)! A clinician's guide to community MRSA - its evolving antimicrobial resistance and implications for therapy.
Chua K; Laurent F; Coombs G; Grayson ML; Howden BP
Clin Infect Dis; 2011 Jan; 52(1):99-114. PubMed ID: 21148528
[TBL] [Abstract][Full Text] [Related]
4. Empirical therapy for serious Gram-positive infections: making the right choice.
Segreti J
Clin Microbiol Infect; 2009 Dec; 15 Suppl 6():5-10. PubMed ID: 19917021
[TBL] [Abstract][Full Text] [Related]
5. [Antibiotic susceptibility of Staphylococcus aureus strains isolated in two university hospitals in Rabat, Morocco].
Elhamzaoui S; Benouda A; Allali F; Abouqual R; Elouennass M
Med Mal Infect; 2009 Dec; 39(12):891-5. PubMed ID: 19269758
[TBL] [Abstract][Full Text] [Related]
6. [Characterisation and public health risks of antimicrobial resistance in Staphylococcus aureus in intensive rabbit breeding].
Ortega C; Simón MC; Alonso JL; Mateo A
Rev Sci Tech; 2009 Dec; 28(3):1119-28. PubMed ID: 20462171
[TBL] [Abstract][Full Text] [Related]
7. Alternatives to vancomycin for the treatment of methicillin-resistant Staphylococcus aureus infections.
Micek ST
Clin Infect Dis; 2007 Sep; 45 Suppl 3():S184-90. PubMed ID: 17712745
[TBL] [Abstract][Full Text] [Related]
8. Microbiologic characteristics and in vitro susceptibility to antimicrobials in a large population of patients with cardiovascular implantable electronic device infection.
Jan E; Camou F; Texier-Maugein J; Whinnett Z; Caubet O; Ploux S; Pellegrin JL; Ritter P; Metayer PL; Roudaut R; Haissaguerre M; Bordachar P
J Cardiovasc Electrophysiol; 2012 Apr; 23(4):375-81. PubMed ID: 22082221
[TBL] [Abstract][Full Text] [Related]
9. Antimicrobial resistance in clinical isolates of Staphylococcus aureus from hospital and community sources in southern Jamaica.
Brown PD; Ngeno C
Int J Infect Dis; 2007 May; 11(3):220-5. PubMed ID: 16815064
[TBL] [Abstract][Full Text] [Related]
10. In vivo efficacy of the antimicrobial peptide ranalexin in combination with the endopeptidase lysostaphin against wound and systemic meticillin-resistant Staphylococcus aureus (MRSA) infections.
Desbois AP; Gemmell CG; Coote PJ
Int J Antimicrob Agents; 2010 Jun; 35(6):559-65. PubMed ID: 20206480
[TBL] [Abstract][Full Text] [Related]
11. Emerging options for treatment of invasive, multidrug-resistant Staphylococcus aureus infections.
Drew RH
Pharmacotherapy; 2007 Feb; 27(2):227-49. PubMed ID: 17253914
[TBL] [Abstract][Full Text] [Related]
12. Increasing antibiotic resistance among methicillin-resistant Staphylococcus aureus strains.
Sakoulas G; Moellering RC
Clin Infect Dis; 2008 Jun; 46 Suppl 5():S360-7. PubMed ID: 18462091
[TBL] [Abstract][Full Text] [Related]
13. In vitro and in vivo antibiofilm activity of a coral associated actinomycete against drug resistant Staphylococcus aureus biofilms.
Bakkiyaraj D; Pandian SK
Biofouling; 2010 Aug; 26(6):711-7. PubMed ID: 20706890
[TBL] [Abstract][Full Text] [Related]
14. [Antibiotic consumption and antimicrobial susceptibility evolution in the Centro Hospitalario Pereira Rossell in methicillin resistant Staphylococcus aureus era].
Telechea H; Speranza N; Lucas L; Santurio A; Giachetto G; Algorta G; Nanni L; Pírez MC
Rev Chilena Infectol; 2009 Oct; 26(5):413-9. PubMed ID: 19915749
[TBL] [Abstract][Full Text] [Related]
15. Clinical isolates of Staphylococcus aureus from the Arkhangelsk region, Russia: antimicrobial susceptibility, molecular epidemiology, and distribution of Panton-Valentine leukocidin genes.
Vorobieva V; Bazhukova T; Hanssen AM; Caugant DA; Semenova N; Haldorsen BC; Simonsen GS; Sundsfjord A
APMIS; 2008 Oct; 116(10):877-87. PubMed ID: 19132981
[TBL] [Abstract][Full Text] [Related]
16. Increasing prevalence of methicillin resistance in serious ocular infections caused by Staphylococcus aureus in the United States: 2000 to 2005.
Asbell PA; Sahm DF; Shaw M; Draghi DC; Brown NP
J Cataract Refract Surg; 2008 May; 34(5):814-8. PubMed ID: 18471638
[TBL] [Abstract][Full Text] [Related]
17. Staphylococcus aureus with reduced susceptibility to vancomycin--United States, 1997.
Centers for Disease Control and Prevention (CDC)
MMWR Morb Mortal Wkly Rep; 1997 Aug; 46(33):765-6. PubMed ID: 9272582
[TBL] [Abstract][Full Text] [Related]
18. Susceptibility of Staphylococcus aureus isolated from skin and wound infections in the United States 2005-07: laboratory-based surveillance study.
Tillotson GS; Draghi DC; Sahm DF; Tomfohrde KM; Del Fabro T; Critchley IA
J Antimicrob Chemother; 2008 Jul; 62(1):109-15. PubMed ID: 18397923
[TBL] [Abstract][Full Text] [Related]
19. In vitro susceptibility patterns of methicillin-resistant Staphylococcus aureus and coagulase-negative Staphylococcus corneal isolates to antibiotics.
Elsahn AF; Yildiz EH; Jungkind DL; Abdalla YF; Erdurmus M; Cremona FA; Rapuano CJ; Hammersmith KM; Cohen EJ
Cornea; 2010 Oct; 29(10):1131-5. PubMed ID: 20595899
[TBL] [Abstract][Full Text] [Related]
20. Methicillin-resistant Staphylococcus aureus: a community health threat.
Cataldo MA; Taglietti F; Petrosillo N
Postgrad Med; 2010 Nov; 122(6):16-23. PubMed ID: 21084777
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
